Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
2
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Purpose: Gonadotropin-releasing hormone agonist (GnRHa) is known for improvingfinal adult height in patients with central precocious puberty (CPP). This studyaimed to investigate the age of menarche and near adult height in girls with CPPwho had been treated with GnRHa. Methods: In this retrospective study, we reviewed the medical records of 71 Koreangirls with CPP who had started menarche or reached over 13 years of bone ageafter long-term GnRHa treatment. We estimated near adult height using the Bayley-Pinneau method and identified the age of menarche in girls with CPP. Results: Mean chronological and bone age at menarche were 11.9±0.7 and 12.8±0.4years, respectively. The period between menarche and the end of treatment was14.0±5.6 months. Posttreatment near adult height was 163.8±4.7 cm, which wassignificantly greater than pretreatment predicted adult height (158.7±4.1 cm). Conclusion: GnRHa treatment in girls with CPP could improve final adult height andmade the age of menarche close to that of the general population.
Abstract
Purpose: Gonadotropin-releasing hormone agonist (GnRHa) is known for improvingfinal adult height in patients with central precocious puberty (CPP). This studyaimed to investigate the age of menarche and near adult height in girls with CPPwho had been treated with GnRHa. Methods: In this retrospective study, we reviewed the medical records of 71 Koreangirls with CPP who had started menarche or reached over 13 years of bone ageafter long-term GnRHa treatment. We estimated near adult height using the Bayley-Pinneau method and identified the age of menarche in girls with CPP. Results: Mean chronological and bone age at menarche were 11.9±0.7 and 12.8±0.4years, respectively. The period between menarche and the end of treatment was14.0±5.6 months. Posttreatment near adult height was 163.8±4.7 cm, which wassignificantly greater than pretreatment predicted adult height (158.7±4.1 cm). Conclusion: GnRHa treatment in girls with CPP could improve final adult height andmade the age of menarche close to that of the general population.
참고문헌 (22)
- Carel JC, "Clinical practice: precocious puberty", N Engl J Med, 358, pp.2366~2377 (2008)
- Shankar RR, "Precocious puberty", Adv Endocrinol Metab, 6, pp.55~89 (1995)
- Bertelloni S, "Effect of central precocious puberty and gonadotropinreleasing hormone analogue treatment on peak bone mass and final height in females", Eur J Pediatr, 157, pp.363~367 (1998)
- 남효경, "진성 성조숙증 여아에서 Gonadotropin-Releasing Hormone Agonist 치료 중 성장속도에 따른 임상 인자들의 비교", Endocrinology and Metabolism, 25(3), pp.206~212 (2010), 대한내분비학회
- 신정희, "성조숙증으로 진단된 여아에서 성선자극호르몬 방출호르몬 효능약제 치료 후 첫 3개월 성장속도가 1년 후 성장에 미치는 영향", Annals of Pediatirc Endocrinology & Metabolism, 16(2), pp.80~85 (2011), 대한소아내분비학회
- Lee PA, "Efficacy of leuprolide acetate 1-month depot for central precocious puberty (CPP): growth outcomes during a prospective, longitudinal study", Int J Pediatr Endocrinol, 2011, pp.7~ (2011)
- Poomthavorn P, "Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropinreleasing hormone analogue treatment", Gynecol Endocrinol, 27, pp.524~528 (2011)
- Paul D, "Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5years", J Clin Endocrinol Metab, 80, pp.546~551 (1995)
- Bayley N, "Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards", J Pediatr, 40, pp.423~441 (1952)
- Ju Hyun Ahn, "Age at menarche in the Korean female: secular trends and relationship to adulthood body mass index", Annals of Pediatirc Endocrinology & Metabolism, 18(2), pp.60~64 (2013), 대한소아내분비학회
- Cho GJ, "Age at menarche in a Korean population: secular trends and influencing factors", Eur J Pediatr, 169, pp.89~94 (2010)
- Neely EK, "Leuprolide acetate 1-month depot for central precocious puberty: hormonal suppression and recovery", Int J Pediatr Endocrinol, 2010, pp.398639~ (2010)
- Neely EK, "Two-year results of treatment with depot leuprolide acetate for central precocious puberty", J Pediatr, 121, pp.634~640 (1992)
- Mul D, "Auxological and biochemical evaluation of pubertal suppression with the GnRH agonist leuprolide acetate in early and precocious puberty", Horm Res, 51, pp.270~276 (1999)
- Carel JC, "Precocious puberty and statural growth", Hum Reprod Update, 10, pp.135~147 (2004)
- 권은별, "Changes in the Predicted Adult Height after Gonadotropin-Releasing Hormone Agonist Treatment in Girls with Idiopathic True Precocious Puberty", Annals of Pediatirc Endocrinology & Metabolism, 17(3), pp.160~168 (2012), 대한소아내분비학회
- Zachmann M, "Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various pathologic conditions", J Pediatr, 93, pp.749~755 (1978)
- Bar A, "Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height", J Pediatr, 126, pp.955~958 (1995)
- Unrath M, "Automation of bone age reading and a new prediction model improve adult height prediction in children with short stature", Horm Res Paediatr, 78, pp.312~319 (2012)
- Lazar L, "Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity", J Clin Endocrinol Metab, 92, pp.3483~3489 (2007)
- Klein KO, "Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience", J Clin Endocrinol Metab, 86, pp.4711~4716 (2001)
- 채현욱, "Longitudinal Standards for Height and Height Velocity in Korean Children and Adolescents: the Kangwha Cohort Study", Journal of Korean Medical Science, 28(10), pp.1512~1517 (2013), 대한의학회
